Recent advancements in the drug treatment of endocrine diseases

Abstract

-Recent years have seen several advances in the management of endocrine diseases. These include novel drugs developed as a consequence of better understanding of the pathophysiology of endocrine conditions, as well as improved delivery methods for existing drugs. In this article, we summarise recent studies evaluating several drugs used in the treatment of endocrine disorders.

Evidence-based appraisal of situational judgement tests (revisited)

“…We were surprised that the letter by Sam et al 1 commenting on our opinion article 2 responding to their own opinion article 3 primarily mounted a defence of the shift to preference informed allocation, since we ourselves described this as having positive potential.…”

“…Regarding fairness, we don't dispute the presence of F1 SJT score differences between Black and Minority Ethnic (BAME) and White students, as is evident for almost all assessments elsewhere, but we dispute that this equates to the test being `biased' 3 without a more sophisticated causal explanation of the issues, which Sam et al themselves now admit is `unclear'. 1…”

“Out of the frying pan and into the fire” – the UKFPO’s recent changes are a short-sighted response to a complicated problem

“…Having been through finals and the SJT as students ourselves only three years ago, we can attest to just how stressful this period was. Flaws in the SJT are well documented [ 4 ]​. Questions are notoriously rigid and subjective, with similar questions often marked differently based on small changes to wording, with even subject matter ‘experts’ often struggling to agree on the correct responses [ 5 ].…”